BCL3ANT
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C13H10Cl2N4O2S |
| Molar mass | 357.21 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BCL3ANT is an experimental anticancer drug which acts as an inhibitor of BCL3-mediated expression of cyclin D1, which is important for the proliferation and metastasis of certain types of cancer such as lymphoma and melanoma. BCL3ANT is of relatively low potency and is unlikely to be developed as a medicine in its own right, however as the first drug developed which inhibits BCL3-mediated cyclin D1 expression it is of academic interest in this area and is likely to lead to the development of more potent drugs acting through this pathway, which may be useful as anticancer medications.[1]
References
- ^ Saamarthy K, Ahlqvist K, Daams R, Balagunaseelan N, Rinaldo-Matthis A, Kazi JU, et al. (January 2024). "Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells". BMC Cancer. 24 (1) 103. doi:10.1186/s12885-023-11663-y. PMC 10795364. PMID 38238702.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.